A Win For Apimeds Pharmaceuticals US, Inc
Thu, Sep 24, 2026 at 08:10 PM
Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT) rocketted at $4.92, a gain of 114.8%. On Thu, Sep 24, 2026, APUS:NYSEMKT hit a New 2-Week High of $4.92. The stock appeared on our News Catalysts scanner on Thu, Sep 24, 2026 at 09:23 AM in the 'AGREEMENT' category. From Thu, Sep 10, 2026, the stock recorded 50.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Sep 24, 2026 at $8.74 with a volume of 87M+.
About Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT)
Apimeds Pharmaceuticals US is a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally administered bee venom-based toxin which potentially exhibits...
Top 10 Gainers:
- Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT), 114.85%
- Surrozen, Inc. (SRZN:NASDAQ), 108.42%
- Greenland Energy Company (GLND:NASDAQ), 83.85%
- Powell Max Limited (PMAX:NASDAQ), 80.62%
- Profusa Inc. (PFSA:NASDAQ), 47.8%
- YD Bio Limited (YDES:NASDAQ), 47.68%
- Hang Feng Technology Innovation Co. Ltd. (FOFO:NASDAQ), 38.07%
- Springview Holdings Ltd (SPHL:NASDAQ), 35.73%
- Greenland Mines Ltd (GRML:NASDAQ), 33.07%
- Avax One Technology Ltd Com (AVX:NASDAQ), 32.93%